BRWA
SGYP

B. Riley Wealth Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

B. Riley Wealth Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-700
Closed -$2K – 2337
2014
Q4 		$2K Buy
+700
New +$2.07K ﹤0.01% 3469
2014
Q3 		– Sell
-700
Closed -$2.85K – 2179
2014
Q2 		$2.85K Buy
+700
New +$2.97K ﹤0.01% 2170

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

B. Riley Wealth Advisors's SGYP Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2015, closing a stake of 700 shares — an estimated $2K sold.

B. Riley Wealth Advisors first reported a position in SGYP in Q2 2014 and held it in 2 quarters. The position peaked at $2.85K in Q2 2014. 85 funds tracked by Wall St. Rank hold SGYP as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 700 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2015, an estimated $2K.
  • B. Riley Wealth Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2014 and held it in 2 quarters.
  • B. Riley Wealth Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2.85K in Q2 2014.
  • 85 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.